CordovaCann (LVRLF) Revenue (2009 - 2019)
CordovaCann (LVRLF) recorded quarterly Revenue of -$17140.9 in Q2 2019, down 397.17% quarter-over-quarter from $5768.1 in Q1 2019.
CordovaCann (LVRLF) Revenue (2009 - 2019) Analysis & Trends
CordovaCann's Revenue history runs 3 years deep, the most recent figure standing at -$17140.9 for Q2 2019.
- In Q2 2019, Revenue changed N/A year-over-year to -$17140.9; the TTM figure through Jun 2019 stood at $245.4 (changed N/A YoY), while the FY2025 annual figure was $10.2 million, changed 0.28% from the prior year.
- Revenue was -$17140.9 for Q2 2019 at CordovaCann, down from $5768.1 in the prior quarter.
- In the past five years, Revenue ranged from a high of $6977.6 in Q1 2018 to a low of -$17140.9 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 608.10 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 377.33 Mn |
| 10 | CordovaCann | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -17,140.90 |
| Mar 31, 2019 | 5,768.13 |
| Dec 31, 2018 | 5,933.68 |
| Sep 30, 2018 | 5,684.50 |
| Mar 31, 2018 | 6,977.63 |
| Jun 30, 2009 | -27,156.66 |
| Mar 31, 2009 | 25,371.88 |